98%
921
2 minutes
20
Background: Malaria rapid diagnostic tests (RDTs) are an essential tool in managing febrile illnesses in endemic settings. However, persisting parasite antigen after treatment or spontaneous remission, which can be detected by histidine-rich protein 2 (HRP2)-based RDT or Plasmodium lactate dehydrogenase (pLDH)-based RDTs, could lead to misdiagnosis. To overcome the latter, a diagnostic approach combining sequential interpretation of two-step malaria RDTs incorporating two parasite antigens detecting PfHRP2 and pLDH coupled with a direct-on-blood mini PCR-nucleic acid lateral flow immunoassay (dbPCR-NALFIA) has been evaluated.
Methods: Febrile patients visiting two rural health facilities in Burkina Faso were enrolled. For each participant, an HRP2-based RDT and blood slides for microscopy (gold standard) were performed. A capillary blood sample was also collected in an EDTA tube and transported to laboratory to perform the two-step malaria RDT detecting HRP2 and LDH, and dbPCR-NALFIA testing. Malaria diagnostic results were sequentially interpreted and reported as: (i) positive when pLDH line appears regardless of the HRP2 results (PfHRP2 + /pLDH + or PfHRP2-/pLDH +); (ii) negative when both lines are absent (PfHRP2-/pLDH-); and (iii) undetermined when only the HRP2 line appears (PfHRP2 + /pLDH-). Undetermined cases were subsequently confirmed by dbPCR-NALFIA test and reported as positive or negative. Malaria microscopy was used as reference test of conclusive diagnostic results (PfHRP2 + /pLDH + , PfHRP2-/pLDH + or PfHRP2-/pLDH-) and qPCR for undetermined cases (PfHRP2 + /pLDH-).
Results: Out of 438 blood samples analysed, 87.2% (382/438) of patients with conclusive sequential interpretation of HRP2 and pLDH did not need confirmative testing with dbPCR-NALFIA. The sensitivity and specificity of these conclusive results were 98.8% and 95.3%, respectively. Following confirmation of undetermined sequential interpretation with dbPCR-NALFIA, the sequential algorithm had a sensitivity of 97.9%, a specificity of 94.8%, a positive predictive value of 97.2%, and a negative predictive value of 96.1%. For single HRP2-based RDT, the sensitivity was 95.2%, the specificity 73.2%, the positive predictive value 85.1%, and the negative predictive value 90.4%.
Conclusions: The sequential algorithm of the two-step RDTs combined with dbPCR-NALFIA on inconclusive results enhances the diagnosis of malaria in febrile patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12330003 | PMC |
http://dx.doi.org/10.1186/s12936-025-05500-9 | DOI Listing |
Res Sq
August 2025
Laboratorio de Malaria: Parasitos y Vectores, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia.
parasites with deletions of the and () genes, involved in rapid diagnostic test (RDT) failure, have been increasingly predominant in the Peruvian Amazon since 2012. However, the evolutionary factors underlying this phenomenon remain unclear since HRP2-based RDTs have not been commonly used in this region. Here, we characterized the population in Peru (2006-2018) to identify genomic regions with evidence of recent positive selection.
View Article and Find Full Text PDFMalar J
August 2025
Institut de Recherche en Sciences de la Santé - Clinical Research Unit of Nanoro (IRSS-CRUN), 11 BP 218. Ouaga CMS 11, Nanoro, Burkina Faso.
Background: Malaria rapid diagnostic tests (RDTs) are an essential tool in managing febrile illnesses in endemic settings. However, persisting parasite antigen after treatment or spontaneous remission, which can be detected by histidine-rich protein 2 (HRP2)-based RDT or Plasmodium lactate dehydrogenase (pLDH)-based RDTs, could lead to misdiagnosis. To overcome the latter, a diagnostic approach combining sequential interpretation of two-step malaria RDTs incorporating two parasite antigens detecting PfHRP2 and pLDH coupled with a direct-on-blood mini PCR-nucleic acid lateral flow immunoassay (dbPCR-NALFIA) has been evaluated.
View Article and Find Full Text PDFmedRxiv
June 2025
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
The rise of antimalarial drug-resistant poses a major threat to malaria treatment, control, and elimination efforts. Mutations in the () gene confer artemisinin partial resistance (ART-R), compromising the efficacy of combination therapies. In the Horn of Africa, the validated mutation R622I has rapidly emerged in parallel with other mutations elsewhere in Eastern Africa.
View Article and Find Full Text PDFParasit Vectors
July 2025
Institut Pasteur de Dakar, Dakar, Senegal.
Background: The emergence of Plasmodium falciparum (Pf) parasites with deleted histidine-rich protein 2 and 3 (hrp2/hrp3) genes threatens the performance of HRP2-based malaria rapid diagnostic tests (RDTs). RDTs targeting Pf lactate dehydrogenase (LDH) may address current product limitations and improve case management. The objective of this study was to evaluate the performance and usability of three LDH-based RDTs in febrile patients.
View Article and Find Full Text PDFMem Inst Oswaldo Cruz
June 2025
Ministerio de Salud y Protección Social, Subdirección de Enfermedades Transmisibles, Bogotá DC, Colombia.
Background: In malaria-endemic regions, rapid diagnostic tests (RDTs) play a crucial role in promptly identifying infections, especially in remote areas with limited microscopy services.
Objectives: Conduct a cross-sectional, multi-site study to determine whether the local prevalence of mutations in the Plasmodium falciparum hrp2/3 genes in false-negative RDTs has reached a threshold that might require a local or national change in diagnostic strategy in accordance with the WHO guidelines (2018).
Methods: Individuals were screened for P.